| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3735 |
| Trial ID | NCT06227026 |
| Disease | Acute Lymphoblastic Leukemia | Diffuse Large B Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies |
| Year | 2024 |
| Country | United States |
| Company sponsor | University of Utah |
| Other ID(s) | HCI143560 |
| Cohort 1 | |||||||||
|
|||||||||